Assessment of knowledge, understanding and awareness of Chinese women clinical staff towards menopause hormone therapy: a survey study

Figures & data

Table 1. General information regarding the medical staff.

Characteristics	Number of participants (N = 3216)	Percentage
Age, years
20–29	1035	32.2
30–39	971	30.2
40–49	832	25.9
50–59	368	11.4
>60	10	0.3
Professional position
Doctor	936	29.1
Nurse	1778	55.3
Managerial staff member	238	7.4
Technician	264	8.2
Menstrual volume
Oligomenorrhea	377	11.7
Moderate	2135	66.4
Menorrhagia	325	10.1
Amenorrhoea	379	11.8
Menstrual cycle
Regular	2570	79.9
Irregular	646	20.1
Parity
Nulliparous	1251	38.9
Parous	1965	61.1
Induced abortion due to unintended pregnancy
Yes	1135	35.3
No	2081	64.7

Table 2. Knowledge about the benefits and risks of menopausal hormonal therapy.

N = 3216	Agree N (%)	Disagree N (%)	No knowledge N (%)
Relieve menopausal symptoms	616 (19.2)	0 (0)	2600 (80.8)
Prevent and treat osteoporosis	444 (13.8)	181 (5.6)	2591 (80.6)
Reduce the risks of colon cancer	137 (4.3)	68 (2.1)	3011 (93.6)
Increase the risk of venous thrombosis	209 (6.5)	179 (5.6)	2828 (87.9)
Increase the risk of cerebral infarctions	70 (2.2)	154 (4.8)	2992 (93.0)
May increase the risk of breast cancer	430 (13.4)	0 (0)	2786 (86.6)
May increase the risk of endometrial cancer	176 (5.5)	0 (0)	3040 (94.5)

Table 3. Knowledge about the risks and benefits of HT among the different professional groups.

N = 3216	Professional position												χ^2a	p^a
	Doctor (N = 936)			Nurse (N = 1778)			Managerial staff (N = 238)			Technician (N = 264)
	Agree (%)	Disagree (%)	No knowledge (%)	Agree (%)	Disagree (%)	No knowledge (%)	Agree (%)	Disagree (%)	No knowledge (%)	Agree (%)	Disagree (%)	No knowledge (%)
Relieve menopausal symptoms	155 (16.56)	0	781 (83.44)	313 (17.60)	0	1465 (82.40)	77 (32.35)	0	161 (67.65)	71 (26.89)	0	193 (73.11)	43.814	.000
Prevent and treat osteoporosis	128 (13.68)	31 (3.31)	777 (83.01)	226 (12.71)	106 (5.96)	1446 (81.33)	41 (17.23)	19 (7.98)	178 (74.79)	49 (18.56)	25 (9.47)	190 (71.97)	30.668	.000
Reduce the risks of colon cancer	38 (4.06)	19 (2.03)	879 (93.91)	74 (4.16)	36 (2.02)	1668 (93.82)	9 (3.78)	8 (3.36)	221 (92.86)	16 (6.06)	5 (1.89)	243 (92.05)	4.276	.639
Increase the risk of venous thrombosis	83 (8.87)	26 (2.78)	827 (88.35)	100 (5.62)	107 (6.02)	1571 (88.36)	12 (5.04)	22 (9.24)	204 (85.72)	14 (5.30)	24 (9.09)	226 (85.61)	37.286	.000
Increase the risk of cerebral infarctions	28 (2.99)	38 (4.06)	870 (92.95)	34 (1.91)	86 (4.84)	1658 (93.25)	3 (1.26)	13 (5.46)	222 (93.28)	5 (1.89)	16 (6.06)	243 (92.05)	6.651	.354
May increase the risk of breast cancer	110 (11.75)	0	826 (88.25)	205 (11.53)	0	1573 (88.47)	55 (23.11)	0	183 (76.89)	60 (22.73)	0	204 (77.27)	46.760	.000
May increase the risk of endometrial cancer	43 (4.59)	0	893 (95.41)	91 (5.12)	0	1687 (94.88)	24 (10.08)	0	214 (89.92)	18 (6.82)	0	246 (93.18)	12.536	.006

^aOnly the option ‘agree’ was compared.